BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vij M, Rammohan A, Rela M. Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection. World J Hepatol 2022; 14(8): 1541-1549 [PMID: 36157865 DOI: 10.4254/wjh.v14.i8.1541]
URL: https://www.wjgnet.com/1948-5182/full/v14/i8/1541.htm
Number Citing Articles
1
Yu. R. Kamalov, E. Yu. Kryzhanovskaya, A. V. Filin, V. A. Sandrikov. Ultrasound elastography/elastometry and steatometry in liver transplantation. Transplantologiya. The Russian Journal of Transplantation 2026; 18(1) doi: 10.23873/2074-0506-2026-18-1-109-124
2
Delal Akdag, Jeanett Klubien, Andreas Arendtsen Rostved, Allan Rasmussen, Nikolai Kirkby, Gro Linno Willemoe, Deepthi Chiranth, Bo‐Göran Ericzon, Carl Jorns, William Bennet, Arno Nordin, Fredrik Åberg, Jens Georg Hillingsø, Susanne Dam Nielsen, Hans‐Christian Pommergaard. Low Torque Teno Virus Load Is Associated With Fibrosis in Protocol Biopsies Following Liver Transplantation: A Nordic Multicenter Cohort Study. APMIS 2026; 134(9) doi: 10.1111/apm.70254
3
Delal Akdag, Andreas Arendtsen Rostved, Allan Rasmussen, Gro Linno Willemoe, Deepthi Chiranth, Bo‐Göran Ericzon, Carl Jorns, William Bennet, Arno Nordin, Fredrik Åberg, Jens Georg Hillingsø, Susanne Dam Nielsen, Hans‐Christian Pommergaard. Fibrosis in One‐Year Protocol Biopsies After Liver Transplantation Is Associated With Graft Loss: A Multicenter Cohort Study. APMIS 2026; 134(8) doi: 10.1111/apm.70250
4
Samuele Iesari, Francesca Laura Nava, Ilaria Elena Zais, Laurent Coubeau, Mariano Ferraresso, Evaldo Favi, Jan Lerut. Advancing immunosuppression in liver transplantation: A narrative review. Hepatobiliary & Pancreatic Diseases International 2024; 23(5) doi: 10.1016/j.hbpd.2024.03.001
5
Toshiaki Nakano, Shigeru Goto, Chao-Long Chen. Mechanisms of Tolerance Induction in Liver Transplantation: Lessons Learned from Fetomaternal Tolerance, Autoimmunity and Tumor Immunity. International Journal of Molecular Sciences 2024; 25(17) doi: 10.3390/ijms25179331
6
Djordje Milosevic, Marija Brankovic, Mihailo Jovanovic, Janko Djordjevic, Nenad Grujovic, Fatima Zivic. Design of the Amorphous Solid Dispersion (Asd) Drugs by Hot Melt Extrusion (Hme), for the Inhibition of Bone Graft Rejection. 2024 IEEE 24th International Conference on Bioinformatics and Bioengineering (BIBE) 2024;  doi: 10.1109/BIBE63649.2024.10820476
7
Man Luo, Jiapeng Yang, Kai Zhang, Ji Sun, Zhiyu Lu, Zhihao Wang, Yaowei Hu, Jianxin Zhai, Peng Xie, Tana Siqin, Mengran Lang, Xuan Meng, Hongguang Wang. Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviews. International Journal of Surgery 2025; 111(2) doi: 10.1097/JS9.0000000000002206
8
Hanlin L. Wang. Asymptomatic Allograft Fibrosis in Pediatric Liver Transplantation: Potential Clinical Implications. Transplantation 2023; 107(11) doi: 10.1097/TP.0000000000004604
9
Mebrahtu G. Tedla, Mebrihit M. Kahsay, Mebrahtu G. Kidanu. Maintaining the optimum level of immunosuppressive agents minimizes risk of liver allograft fibrosis during pediatric liver transplantation. International Journal of Surgery 2024; 110(6) doi: 10.1097/JS9.0000000000000759
10
Shilpa Chawla, Subholakshmi Choudhury, Amitava Das. Bioengineered MSCGFPCxcr2-Mmp13 Transplantation Alleviates Hepatic Fibrosis by Regulating Mammalian Target of Rapamycin Signaling. Antioxidants & Redox Signaling 2024; 41(1-3) doi: 10.1089/ars.2023.0390
11
Ana Kalamutova, Danaja Plevel, Mihajlo Djokic, Ales Jerin, Blaž Trotovšek, Miha Petric. L-FABP as a Potential Biomolecular Marker of Liver Graft Injury. Journal of Clinical Medicine 2025; 14(20) doi: 10.3390/jcm14207404
12
Mukul Vij. Fundamentals of Transplant Hepatology. 2026;  doi: 10.1007/978-981-95-2624-6_31
13
Annabel Koivu, Ghazal Azarfar, Maryam Shojaee, Naomi K T Hlaing, Sameera Rizvi, Divya Sharma, Saba Maleki, Mamatha Bhat. Machine learning model integrating transient elastography and clinical data for prediction of graft fibrosis after liver transplantation. World Journal of Hepatology 2026; 18(6): 120258 doi: 10.4254/wjh.120258
14
Youwei Zhao, Lijun Wang, Man Xie, Wei Rao. Progress in the diagnosis and treatment of graft fibrosis after liver transplantation. Portal Hypertension & Cirrhosis 2024; 3(1) doi: 10.1002/poh2.70
15
Madhumitha Rabindranath, Rita Zaya, Khairunnadiya Prayitno, Ani Orchanian-Cheff, Keyur Patel, Elmar Jaeckel, Mamatha Bhat. A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. Transplantation Direct 2023; 9(11) doi: 10.1097/TXD.0000000000001547
16
S. E. Voskanyan, V. E. Syutkin, A. I. Sushkov, Yu. V. Voskanyan, A. Yu. Veselkova. Liver allograft pathology in the late post-transplant period. Transplantologiya. The Russian Journal of Transplantation 2023; 15(3) doi: 10.23873/2074-0506-2023-15-3-359-375
17
Catalina Jaramillo, Parmjeet Randhawa, Amrita Narang, Alison J. Gareau, Jody Weckwerth, Alisha Mavis, George Mazariegos, Katryn Furuya, Nanda Kerkar. An Approach to Antibody‐Mediated Rejection in Pediatric Liver Transplantation. Pediatric Transplantation 2026; 30(9) doi: 10.1111/petr.70455
18
Nourhan Badwei. Hepatic allograft rejection after liver transplantation: Clinicopathological debates!. iLIVER 2023; 2(2) doi: 10.1016/j.iliver.2023.05.003
19
Alisa Kielkowski, Alejandro Campos-Murguia, Emily A. Bosselmann, Sophia Heinrich, Björn Hartleben, Heiner Wedemeyer, Bastian Engel, Elmar Jaeckel, Richard Taubert. Long-term renal benefit of a biopsy-guided personalized calcineurin inhibitor–sparing regimen late after liver transplantation. Liver Transplantation 2026;  doi: 10.1097/LVT.0000000000000950